gassan.massarweh [at] mcgill.ca (Dr. Gassan Massarweh), Assistant Professor & Director Cyclotron and Radiochemistry Core
Dr Massarweh's group focusses on cutting-edge developments in radiochemistry along the following principal axes of research:
- Neurodegenerative diseases: The development and in-vivo evaluation of novel PET radiotracers for Alzheimer’s and Parkinson’s diseases to target β–Amyloid plaques, Tau protein and α–Synuclein protein using fluorine-18 and carbon-11;
- Oncology, cancer: The development and evaluation in vivo and in vitro of novel PET radiotracers to target brain, breast and prostate cancer;
- Radiolabeling methods: The development of novel synthetic methods using organic and inorganic catalysts for rapid radiolabeling of organic compounds;
- Radiometal complexes: The development of radiometal complexes for diagnostic and therapeutic applications in oncology. The development includes metal complex synthesis and radiochemical synthesis.